Aridis intends to advance its proprietary products portfolio to initial clinical safety and efficacy endpoints, then form strategic partnerships with companies that have the necessary commercialization infrastructures to best capture value. However, we are interested in forging partnership alliances at all development stages should such arrangements facilitate the rapid development of the product.

We are also interested in collaborations with development partners who have thermally labile or difficult to deliver products, which could take advantage of our unique combination of stabilization, delivery and development expertise.

For partnership inquiries, please contact:
Eric J. Patzer, Ph.D.
President

Aridis Pharmaceuticals
5941 Optical Court
San Jose, CA 95138
Phone: 408-385-1742
Fax: 408-960-3822
Email: patzere@aridispharma.com